.Novo Nordisk is continuing its press into hereditary medications, consenting to pay NanoVation Ther...
.Innovent Biologics has actually produced the situation that its own checkpoint inhibitor-cytokine c...
.A stage 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.Five months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech ha...
.Ascendis Pharma has become a prospective risk to BioMarin's Voxzogo, mentioning stage 3 growth ailm...
.Though Alkeus Pharmaceuticals' dental eye disease possession neglected to significantly reduce geog...
.Along with a trio of biotechs hitting the Nasdaq on Friday, it was easy to miss a smaller-scale soc...
.Invulnerable gate preventions are the superheroes of cancer therapy. Medicines like Bristol Myers S...
.Welcome to this week's Chutes & Ladders, our roundup of significant management hirings, firings ...
.Regeneron is actually back with long-term consequence for its LAG-3 inhibitor as well as PD-1 preve...